Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EOLS | US
0.06
0.38%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
30/08/2024
15.89
15.85
16.02
15.67
Evolus Inc. a performance beauty company provides medical aesthetic products for physicians and their patients in the United States. The company offers Jeuveau a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It serves self-pay aesthetic healthcare market. Evolus Inc. was incorporated in 2012 and is headquartered in Newport Beach California.
View LessPositive Momentum
Strong Revenue Growth (> 10%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
38.9%1 month
55.3%3 months
45.8%6 months
40.3%-
98.04
48.05
6.56
0.54
-21.50
4.05
-
-24.64M
1.00B
1.00B
-
-9.11
-
35.60
-861.68
10.32
7.81
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.73
Range1M
4.08
Range3M
6.05
Rel. volume
0.80
Price X volume
7.56M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
PetIQ Inc | PETQ | Drug Manufacturers-Specialty & Generic | 30.55 | 913.01M | 0.10% | 82.57 | 178.54% |
Phibro Animal Health Corporation | PAHC | Drug Manufacturers-Specialty & Generic | 21 | 850.58M | -2.19% | 324.33 | 204.74% |
Ironwood Pharmaceuticals Inc | IRWD | Drug Manufacturers-Specialty & Generic | 5.06 | 808.28M | -0.98% | 62.00 | -199.01% |
Pacira Pharmaceuticals Inc | PCRX | Drug Manufacturers-Specialty & Generic | 15.56 | 717.73M | 1.30% | 10.34 | 73.76% |
Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 5.21 | 575.57M | 0.58% | n/a | 117.00% |
Radius Health Inc | RDUS | Drug Manufacturers-Specialty & Generic | 15.14 | 421.49M | 0.13% | n/a | 0.00% |
Aquestive Therapeutics Inc | AQST | Drug Manufacturers-Specialty & Generic | 4.53 | 412.50M | 2.95% | n/a | -329.45% |
Organogenesis Holdings Inc | ORGO | Drug Manufacturers-Specialty & Generic | 2.88 | 381.82M | -0.69% | n/a | 42.12% |
Cipher Pharmaceuticals Inc | CPHRF | Drug Manufacturers-Specialty & Generic | 14.05 | 359.52M | 0.79% | 14.64 | 0.00% |
Solid Biosciences Inc | SLDB | Drug Manufacturers-Specialty & Generic | 8.93 | 344.66M | -1.11% | n/a | 13.09% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Interface Inc | TILE | Textile Manufacturing | 18.88 | 1.10B | 0.16% | 15.75 | 106.26% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 21.94 | 990.13M | 0.14% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 36.37 | 743.39M | 4.66% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.25 | 722.36M | 0.32% | 51.36 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 23.91 | 621.28M | 1.18% | 14.36 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.48 | 524.97M | 0.55% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 12.45 | 391.86M | -0.16% | 45.64 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 24.03 | 385.84M | 0.33% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.4 | 326.35M | 0.00% | 12.38 | 0.00% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 28.64 | 316.93M | -0.52% | 16.58 | -621.78% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -21.50 | - | Cheaper |
Ent. to Revenue | 4.05 | - | Cheaper |
PE Ratio | - | 28.13 | - |
Price to Book | 48.05 | 11.07 | Expensive |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 45.81 | - | Lower Risk |
Debt to Equity | 6.56 | -0.91 | Expensive |
Debt to Assets | 0.54 | 0.45 | Expensive |
Market Cap | 1.00B | - | Emerging |